Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety, tolerability, effectiveness,
and pharmacokinetics (PK) of twice daily oral doses of V81444 in adults with ADHD.
Pharmacokinetics (PK) is the study of how a drug is absorbed, distributed, metabolized, and
eventually eliminated by the body. Pharmacokinetics is what the body does to the drug. Blood
samples will be taken throughout the study for PK analysis.